BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36509135)

  • 1. Cascadion™ SM Clinical Analyzer: Evaluation of the whole blood immunosuppressants quantification and routine usability.
    Mathieu E; Duterme C; Fage D; Cotton F
    Clin Chim Acta; 2023 Jan; 539():97-104. PubMed ID: 36509135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine.
    Hörber S; Peter A; Lehmann R; Hoene M
    Clin Chem Lab Med; 2021 Apr; 59(5):913-920. PubMed ID: 33068377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory comparison study of immunosuppressant analysis using a fully automated LC-MS/MS system.
    Zahr N; Duce H; Duffy J; Webster C; Rentsch KM
    Clin Chem Lab Med; 2022 Oct; 60(11):1753-1762. PubMed ID: 36044751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory.
    Benton SC; Tetteh GK; Needham SJ; Mücke J; Sheppard L; Alderson S; Ruppen C; Curti M; Redondo M; Milan AM
    Clin Chem Lab Med; 2020 Jun; 58(6):1010-1017. PubMed ID: 31851610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex Immunosuppressant (ISD) Method for the Measurement of Cyclosporine A, Tacrolimus, Sirolimus/Rapamycin, and Everolimus in Whole Blood Using MassTrak™ Kit.
    Zhang A; Conklin SE
    Methods Mol Biol; 2024; 2737():307-318. PubMed ID: 38036832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressant Monitoring-Performance of the First Mass Spectrometry-Based Automated Clinical Analyzer Cascadion.
    Grote-Koska D; Czajkowski S; Staaden A; Brand K
    Ther Drug Monit; 2023 Feb; 45(1):14-19. PubMed ID: 36301627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
    Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
    Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS device.
    Deprez S; Van Uytfanghe K; Stove CP
    Anal Chim Acta; 2023 Feb; 1242():340797. PubMed ID: 36657891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salting Out-Assisted Liquid-Liquid Extraction for Liquid Chromatography-Tandem Mass Spectrometry Measurement of Tacrolimus, Sirolimus, Everolimus, and Cyclosporine a in Whole Blood.
    Kvamsøe MM; Hansen KR; Skadberg Ø; Vethe NT; Brede C
    Ther Drug Monit; 2020 Oct; 42(5):695-701. PubMed ID: 32701594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy evaluation of Roche and Siemens tacrolimus and cyclosporine assays in comparison with liquid chromatography-tandem mass spectrometry.
    Ko DH; Cho EJ; Lee W; Chun S; Min WK
    Scand J Clin Lab Invest; 2018 Oct; 78(6):431-438. PubMed ID: 30270673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-throughput LC-MS/MS method for the quantification of four immunosu- ppressants drugs in whole blood.
    Gong ZS; Wu ZH; Xu SX; Han WN; Jiang XM; Liu HP; Yan-Li ; Wei-Hu ; Yan-Wang
    Clin Chim Acta; 2019 Nov; 498():21-26. PubMed ID: 31351928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated LC-MS/MS: Ready for the clinical routine Laboratory?
    Junger S; Hoene M; Shipkova M; Danzl G; Schöberl C; Peter A; Lehmann R; Wieland E; Braitmaier H
    J Mass Spectrom Adv Clin Lab; 2023 Nov; 30():1-9. PubMed ID: 37583571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
    Becker S; Thiery J; Ceglarek U
    Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
    Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
    Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.
    Koster RA; Veenhof H; Botma R; Hoekstra AT; Berger SP; Bakker SJ; Alffenaar JC; Touw DJ
    Bioanalysis; 2017 Apr; 9(7):553-563. PubMed ID: 28300419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.
    Marinova M; Artusi C; Brugnolo L; Antonelli G; Zaninotto M; Plebani M
    Clin Biochem; 2013 Nov; 46(16-17):1723-7. PubMed ID: 24012696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.
    Meinitzer A; Gartner G; Pilz S; Stettin M
    Ther Drug Monit; 2010 Feb; 32(1):61-6. PubMed ID: 20010460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of non-contact hematocrit prediction technologies to overcome hematocrit effects on immunosuppressant quantification from dried blood spots.
    Deprez S; Heughebaert L; Boffel L; Stove CP
    Talanta; 2023 Mar; 254():124111. PubMed ID: 36462285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.